For instance, the PI3K/AKT/mTOR pathway has been identified as a critical axis in ESCC progression, with mutations in PIK3CA and loss of PTEN frequently observed in ESCC patients [18]. Here, PIK3CA is linked to esophageal squamous cell carcinoma.